MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
RapidRAW is a modern, high-performance alternative to Adobe Lightroom®. It delivers a simple, beautiful editing experience in a lightweight package (under 20MB) for Windows, macOS, and Linux. I ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果